Atea Pharmaceuticals Stock Buy Hold or Sell Recommendation

AVIR -  USA Stock  

USD 25.04  0.69  2.83%

Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Atea Pharmaceuticals is 'Strong Hold'. Macroaxis provides Atea Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AVIR positions. The advice algorithm takes into account all of Atea Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.

Search Advice 

 
Refresh
The advice is provided from Atea Pharmaceuticals' buy-and-hold perspective. Please continue to Atea Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Atea Pharmaceuticals and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Atea Pharmaceuticals.

Execute Atea Pharmaceuticals Buy or Sell Advice

The Atea Pharmaceuticals recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Atea Pharmaceuticals. Macroaxis does not own or have any residual interests in Atea Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Atea Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Atea PharmaceuticalsBuy Atea Pharmaceuticals
Strong Hold

Volatility

Not too volatileDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Quite HighDetails

Economic Sensitivity

Barely shadows the marketDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Atea Pharmaceuticals has a Risk Adjusted Performance of 0.0135, Jensen Alpha of 0.0241, Total Risk Alpha of (0.19), Sortino Ratio of (0.001038) and Treynor Ratio of 1.05
Our investment recommendation module complements current analysts and expert consensus on Atea Pharmaceuticals. It analyzes the firm potential to grow using all fundamental, technical, and market related data available at the time. To make sure Atea Pharmaceuticals is not overpriced, please confirm all Atea Pharmaceuticals fundamentals, including its cash and equivalents, total asset, and the relationship between the price to sales and short ratio . Given that Atea Pharmaceuticals has a number of shares shorted of 4.25 M, we suggest you to validate Atea Pharmaceuticals market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Atea Pharmaceuticals Trading Alerts and Improvement Suggestions

Atea Pharmaceuticals has very high historical volatility over the last 90 days
Atea Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 48.63 M. Net Loss for the year was (10.95 M) with profit before overhead, payroll, taxes, and interest of 33.65 M.
Atea Pharmaceuticals has a poor financial position based on the latest SEC disclosures
About 58.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.equities.com: Atea Pharmaceuticals Inc gains 2.83 percent for July 30 - Equities.com

Atea Pharmaceuticals current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Atea Pharmaceuticals analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Atea Pharmaceuticals analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price35.00
Target Median Price35.00
Target High Price35.00
Recommendation Mean1.70
Number Of Analyst Opinions1
Target Low Price35.00
Average Consensus Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Atea Pharmaceuticals Returns Distribution Density

The distribution of Atea Pharmaceuticals' historical returns is an attempt to chart the future uncertainty of Atea Pharmaceuticals' future price movements. The chart of the probability distribution of Atea Pharmaceuticals stock daily returns describes the distribution of returns around its average expected value. We use Atea Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Atea Pharmaceuticals returns is essential to provide solid investment advice for Atea Pharmaceuticals stock.
Mean Return0.0348Value At Risk-7.92
Potential Upside8.73Standard Deviation5.17
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Atea Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Atea Pharmaceuticals Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Atea Pharmaceuticals or Pharmaceutical Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Atea Pharmaceuticals stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Atea Pharmaceuticals stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
0.024062
β
Beta against DOW0.0237
σ
Overall volatility
5.10
Ir
Information ratio -0.001

Atea Pharmaceuticals Volatility Alert

Atea Pharmaceuticals exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Atea Pharmaceuticals individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about Atea Pharmaceuticals future systematic risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Atea Pharmaceuticals' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Atea Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Atea Pharmaceuticals Fundamentals Vs Peers

Comparing Atea Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Atea Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Atea Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Atea Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Atea Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Atea Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Atea Pharmaceuticals to competition
FundamentalsAtea PharmaceuticalsPeer Average
Return On Equity(3.86) %(0.31) %
Return On Asset1.70 %(0.14) %
Profit Margin(22.51) %(1.27) %
Operating Margin24.70 %(5.51) %
Current Valuation1.05 B16.62 B
Shares Outstanding82.74 M571.82 M
Shares Owned by Insiders18.48 %10.09 %
Shares Owned by Institutions58.09 %39.21 %
Number of Shares Shorted4.25 M4.71 M
Price to Earning(1.01) X28.72 X
Price to Book2.28 X9.51 X
Price to Sales44.32 X11.42 X
Revenue48.63 M9.43 B
Gross Profit33.65 M27.38 B
EBITDA12.03 M3.9 B
Net Income(10.95 M)570.98 M
Cash and Equivalents850.12 M2.7 B
Cash per Share10.27 X5.01 X
Current Ratio2.73 X2.16 X
Book Value Per Share13.09 X1.93 K
Cash Flow from Operations296.73 M971.22 M
Short Ratio11.26 X4.00 X
Earnings Per Share(0.64) X3.12 X
Number of Employees3918.84 K
Beta0.37-0.15
Market Capitalization2.16 B19.03 B
Total Asset97.97 M29.47 B
Retained Earnings(269.19 M)9.33 B
Working Capital91.63 M1.48 B
Current Asset97.88 M9.34 B
Current Liabilities6.25 M7.9 B
Z Score-2.88.72
   Acquisition by Lucidi Bruno of 34025 shares of Atea Pharmaceuticals subject to Rule 16b-3 [view details]

About Atea Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Atea Pharmaceuticals? Buying financial instruments such as Atea Pharmaceuticals Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Atea Pharmaceuticals investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2015 2016 2020 2021 (projected)
Accounts Payable3.9 M1.4 M131.4 K134.86 K
Receivables700 K600 K895.5 K919.07 K

Use Investing Ideas to Build Portfolios

In addition to having Atea Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Latest Losers Thematic Idea Now

Latest Losers
Latest Losers Theme
Dynamically computed list of top equities currently sorted across major exchanges. Latest Losers theme has 117 constituents.
View All  Next Launch Latest Losers
Please continue to Atea Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Atea Pharmaceuticals information on this page should be used as a complementary analysis to other Atea Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Atea Pharmaceuticals Stock analysis

When running Atea Pharmaceuticals price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
The market value of Atea Pharmaceuticals is measured differently than its book value, which is the value of Atea Pharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Atea Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Atea Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea Pharmaceuticals' market value can be influenced by many factors that don't directly affect Atea Pharmaceuticals underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Atea Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.